Recent Articles from GlobeNewswire

SHANGHAI, March 13, 2026 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial results for the full year of 2025 and provided corporate updates.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Driven Brands To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Helen of Troy To Contact Him Directly To Discuss Their Options

LOS ANGELES, March 13, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Paysafe Limited (“Paysafe” or “the Company”) (NYSE: PSFE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In BlackRock TCP To Contact Him Directly To Discuss Their Options

LOS ANGELES, March 13, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Inovio Pharmaceuticals, Inc. (“Inovio” or “the Company”) (NASDAQ: INO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Beyond Meat To Contact Him Directly To Discuss Their Options

LOS ANGELES, March 13, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against uniQure N.V. (“uniQure” or “the Company”) (NASDAQ: QURE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In BellRing To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Enphase To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Beta Bionics To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Hub Group To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Endeavor To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Trip.com To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Bath & Body Works To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Duolingo To Contact Him Directly To Discuss Their Options

LOS ANGELES, March 13, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Masonite International Corporation (“Masonite” or “the Company”) (NYSE: DOOR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inovio To Contact Him Directly To Discuss Their Options

LOS ANGELES, March 13, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or “the Company”) (NASDAQ: RARE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Lakeland To Contact Him Directly To Discuss Their Options

BOCA RATON, Fla., March 13, 2026 (GLOBE NEWSWIRE) -- NewtekOne, Inc. (“the Company”) (NASDAQ: NEWT) announced that its Board of Directors declared a quarterly cash dividend of $0.19 per share on the Company’s outstanding common stock. The dividend is payable on April 1, 2026, to shareholders of record as of March 24, 2026.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Zynex To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Smart Digital To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Wealthfront To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding In Navan To Contact Him Directly To Discuss Their Options

Company and Investor Mutually Agree to Terminate Previously Announced Strategic Private Placement

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Kyndryl To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Soleno To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ultragenyx To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Snowflake To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In uniQure To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Mereo BioPharma To Contact Him Directly To Discuss Their Options

PHILADELPHIA, March 13, 2026 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC announces that a class action lawsuit has been filed against BellRing Brands, Inc. (NYSE: BRBR) (“BellRing” or the “Company”) on behalf of investors who purchased or otherwise acquired BellRing securities during the period of November 19, 2024 through August 4, 2025 (the “Class Period”).

SYDNEY, March 13, 2026 (GLOBE NEWSWIRE) -- Global online FX and CFD broker Axi today confirmed its participation at Invest Cuffs 2026, taking place March 20th–21st at the ICE Kraków Congress Centre in Kraków, Poland.

Former Notre Dame Goalie & Current Deputy Commissioner to take over March 13

TAMPA, Fla., March 13, 2026 (GLOBE NEWSWIRE) -- Specialty leaders from across the country are gathering at Nextech EDGE 2026, the company’s annual user conference designed to bring together customers, partners, and industry experts to collaborate on the future of specialty care.

Addition of Fire Safety, Inc. further expands Sciens’ Southeast presence and adds to its growing nationwide platform

NYC-based investor David Ebrahimzadeh brings capital, industrial real estate infrastructure, and build-to-suit capabilities to Austin — actively seeking investment targets across defense, aerospace, space, manufacturing, quantum, and hard tech

NEW YORK, March 13, 2026 (GLOBE NEWSWIRE) -- CertiK, the largest Web3 security services provider, released its Skynet Crypto ATM Fraud Report, an analysis of the rapidly expanding fraud ecosystem surrounding cryptocurrency kiosks. The report examines the mechanics of crypto ATM scams, global trends in financial losses, attacker infrastructure, enforcement actions, and strategies for mitigation.

CALABASAS, Calif., March 13, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) (“NeOnc” or the “Company”), a multi-Phase 2 clinical-stage biopharmaceutical company developing novel therapies for central nervous system (CNS) cancers, has appointed David Choi as Chief Accounting Officer. In this role, Mr. Choi is responsible for overseeing the Company’s accounting, financial reporting, internal controls, and corporate governance functions as NeOnc advances its clinical-stage biotechnology platform and expands its global operations.

Groundbreaking First-in-Human Study Demonstrates Potential to Treat Type 1 Diabetes by Transplanting Insulin-Secreting Cells Without Immunosuppression

Kfar Saba, Israel, March 13, 2026 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, today announced it has received a new purchase order from an Israeli defense entity for its DefendAir Counter-Unmanned Aerial Systems (Counter-UAS) solution.

Let’s Evolve and Stop Using the R-Word this World Down Syndrome Day and Beyond

NEW YORK, March 13, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that presentations from the Life Sciences Virtual Investor Forum, held March 11th – 12th, are now available for on-demand viewing.

New platform feature allows borrowers to explore personalized mortgage options and lock rates instantly without speaking to a loan officer

BOSTON, March 13, 2026 (GLOBE NEWSWIRE) -- Today, Workable announced the launch of Workable Agent, an AI recruiting agent built directly into its ATS. More than an add-on or isolated feature, Workable Agent brings agency-level recruiting capability directly inside the hiring platform. It acts as a full-cycle hiring teammate that helps teams define the job, source candidates, engage talent, and deliver qualified candidates ready for interview.

GRAND CAYMAN, Cayman Islands, March 13, 2026 (GLOBE NEWSWIRE) -- Activate Energy Acquisition Corp. (NASDAQ: AEAQ) (the “Company”), a special purpose acquisition company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses, today announced that it has filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “Annual Report”) with the U.S. Securities and Exchange Commission (“SEC”).

RESTON, Va., March 13, 2026 (GLOBE NEWSWIRE) -- Science Applications International Corp. (NASDAQ: SAIC) announced today that the company’s board of directors declared a cash dividend of $0.37 per share of the company’s common stock payable on April 24, 2026 to stockholders of record on April 10, 2026.

NEW YORK, March 13, 2026 (GLOBE NEWSWIRE) -- WeRide Inc. (“WeRide” or the “Company”) (Nasdaq: WRD; HKEx: 0800), a global leader in autonomous driving technology, today announced that each of the proposed resolutions submitted for shareholders’ approval (the “Proposed Resolutions”) as set forth in the notice of extraordinary general meeting, notice of Class A meeting and notice of Class B meeting, each dated February 6, 2026, Beijing time, have been adopted at the meetings held in Guangzhou, Guangdong Province, China today.

SINGAPORE, March 13, 2026 (GLOBE NEWSWIRE) -- BitFuFu Inc., (“BitFuFu” or “the Company”) (NASDAQ: FUFU), a world-leading Bitcoin miner and mining services innovator, today announced that it will release its full year financial results for the periods ended December 31, 2025, before the U.S. market open on March 20, 2026.

Gil Efron to Step Down as CEO in August 2026 for Health Considerations; Will Continue to Lead Corporate Development

SHENZHEN, China, March 13, 2026 (GLOBE NEWSWIRE) -- MicroCloud Hologram Inc. (NASDAQ: HOLO), ("HOLO" or the "Company"), a technology service provider, has made an initial estimate through its financial department, predicting that the net profit attributable to shareholders of the listed Company for the year 2025 will show a loss compared to the same period last year.

IRVINE, Calif., March 13, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced it will release its financial results for the fourth quarter and fiscal year ended December 31, 2025, before U.S. market open on March 27, 2026. 

Scottsdale, AZ, March 13, 2026 (GLOBE NEWSWIRE) -- Signing Day Sports, Inc. (“Signing Day Sports”, “SGN” or the “Company”) (NYSE American: SGN), in connection with the Company’s previously announced proposed business combination (the “Business Combination”) with One Blockchain LLC (“BlockchAIn LLC”), BlockchAIn Digital Infrastructure, Inc. (“BlockchAIn Inc.” and together with BlockchAIn LLC, “BlockchAIn”), and certain affiliates of BlockchAIn, today announced that BlockchAIn LLC has entered into a non‑binding letter of intent (“LOI”) with an international private equity firm for a build‑to‑suit data center lease designed to support next‑generation AI infrastructure deployments.

GERMANTOWN, Md., March 13, 2026 (GLOBE NEWSWIRE) -- Barinthus Biotherapeutics plc (NASDAQ: BRNS) (“Barinthus Bio,” or the “Company”), today announced its financial results for the year ended December 31, 2025, and provided an overview of the Company’s corporate developments. Barinthus Bio is an immunology and inflammation (“I&I”) company focused on developing therapies that promote immune tolerance with curative potential.

Positions Lifeward as a diversified biomedical innovation company with clear path to profitability

Integration Strengthens New Engine of Growth, Quality Standards, and Gains U.S. No 4 Spot

Las Vegas, Nevada, March 13, 2026 (GLOBE NEWSWIRE) -- SUMA Acquisition Corporation (NASDAQ: SUMAU) (the “Company”) today announced the closing of its initial public offering of 17,250,000 units, which includes 2,250,000 units issued pursuant to the full exercise by the underwriters of their over-allotment option. The offering was priced at $10.00 per unit, resulting in gross proceeds of $172,500,000. Of the proceeds received from the consummation of the initial public offering and a simultaneous private placement of units, $172,500,000 was placed in the Company’s trust account for the benefit of the Company’s public shareholders.

PRINCETON, N.J., March 13, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd., a biotechnology company dedicated to developing innovative therapies for urothelial and specialty cancers, today commended the Bladder Cancer Advocacy Network (BCAN) on its release of The New Faces of Bladder Cancer Report, a national patient-reported survey underscoring the chronic and recurrent nature of bladder cancer.

Reconstructed Ancestors sets a new industry standard to help reveal deeper family connections and fill gaps in a family tree with greater precision.

MACAU, March 13, 2026 (GLOBE NEWSWIRE) -- Studio City International Holdings Limited (NYSE: MSC) (“Studio City” or the “Company”), a world-class integrated resort located in Cotai, Macau, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2025. The annual report can be accessed under the Annual Reports section on the Company’s investor relations website at https://ir.studiocity-macau.com/annual-reports.

Innovative non-hallucinogenic approach combines MEAI with Palmitoylethanolamide to tackle major depressive disorder, addressing a surging market expected to surpass $25 billion by 2030

PARIS, March 13, 2026 (GLOBE NEWSWIRE) -- DENZA, the premium technology-oriented automotive brand of the BYD Group, is proud to confirm that its stunning Z9GT flagship will introduce game-changing FLASH Charging and the unique principle of 'Ready in 5, Full in 9, Cold Add 3' to European customers when it is officially launched at an event at Paris's Palais Garnier opera house on 8 April.

BERKELEY, Calif., March 13, 2026 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ: QUCY) doing business as Quantum Cyber, today announced, effective upon the commencement of trading on March 12, 2026 (U.S. Eastern Time), it officially changed its ticker symbol to "QUCY" on the Nasdaq Capital Market. Further the Company’s name will change to Quantum Cyber N.V. (“Quantum” or “Company”) effective with a general meeting of shareholders planned for April 2026.

SANTA CLARA, Calif., March 13, 2026 (GLOBE NEWSWIRE) -- Applied Materials, Inc. today announced that its Board of Directors has approved a 15-percent increase in the quarterly cash dividend, from $0.46 to $0.53 per share, payable on June 11, 2026 to shareholders of record as of May 21, 2026. This marks nine consecutive years of dividend increases.

Findings highlight the need for expanding screening and identity verification across the employee lifecycle, risk and speed priorities, and the requirement for simplified processes

Joint Team Continues to Progress Towards Completing an Integrated Uncrewed Collaborative Combat Aircraft (UCCA) System for the German Air Force

AC Immune Reports Full Year 2025 Financial Results and Provides a Corporate Update

Fourth Quarter Revenue Reaches $43.1 MillionExchange Service Revenue Up 48% YoYSelf Service Revenue Up 23% Sequentially Entering 2026 With Improved Operating Structure

National BCAN report highlights diagnostic delays, mental health gaps and financial strain

NEW YORK, March 13, 2026 (GLOBE NEWSWIRE) -- Lotus Technology Inc. (“Lotus Tech” or the “Company”) (Nasdaq: LOT), a leading global intelligent and luxury mobility provider, today announced that the Company has been certified under UN Regulation No. 171, 01 Series (UN R171.01) issued by the United Nations Economic Commission for Europe (UNECE), becoming the second globally operating automaker to achieve this certification.

DUBAI, United Arab Emirates, March 13, 2026 (GLOBE NEWSWIRE) -- On January 29‚ 2026, Founders Connects hosted Founders Meet Up | B2B Networking for startup founders‚ investors‚ and ecosystem partners‚ to ease quality peer-to-peer interactions in an exclusive and impactful format that goes beyond simple networking․

FY 2025 net revenue of $272.1 million, flat to FY 2024, and Adjusted EBITDA of $16.1 million

CAMBRIDGE, Mass., March 13, 2026 (GLOBE NEWSWIRE) -- Akamai (NASDAQ: AKAM) today announced Digital Convergence Technologies (DCT), a system integration and digital transformation company that simplifies complex IT challenges through its “converge and deliver” philosophy, has joined the Akamai Partner Connect Program. DCT enables mid-market and enterprise clients to leverage a specialized refactoring practice for migrating workloads to Akamai, providing a streamlined, cost-effective path to cloud modernization that was previously fragmented across multiple vendors.

BROOKLYN, N.Y., March 13, 2026 (GLOBE NEWSWIRE) -- Voyager Acquisition Corporation (NASDAQ: “VACHU,” “VACH,” “VACHW”) (“Voyager” or the “Company”) held the general meeting on March 12, 2026 and approved the previously announced business combination (the “Business Combination”) with VERAXA Biotech AG (“VERAXA”). After the closing of the Business Combination, it is expected that the combined company will trade on Nasdaq under the new symbol (“VRXA”). As previously announced, holders of 25,217,315 of the Company's Class A ordinary shares (“Class A shares”) exercised their right to redeem their shares for a pro rata portion of the funds in the Company's trust account, reflecting redemptions of approximately 99.67% of the total Class A shares outstanding in connection with the completion of the Business Combination pursuant to the business combination agreement between the Company, VERAXA and the other parties thereto (the “Business Combination Agreement”). The 25,217,315 Class A shares, which were submitted for redemption, have not been withdrawn and will accordingly be redeemed pursuant to the option to redeem provided to holders of the Company’s Class A shares. As a result, assuming redemption elections are not withdrawn or reversed, following the effectuation of redemptions approximately $885,556 will remain in the Company's trust account and 82,685 Class A shares will convert into shares of the combined company, Veraxa Biotech Holding AG.